Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Autoimmune Disorders01:29

Autoimmune Disorders

1.5K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.5K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Stem Cell Culture01:17

Stem Cell Culture

6.0K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frequency of MED12 Mutation in Relation to Tumor and Patient's Clinical Characteristics: a Meta-analysis.

Reproductive sciences (Thousand Oaks, Calif.)·2021
Same author

Low-temperature gas-phase formation of indene in the interstellar medium.

Science advances·2021
Same author

Intra-platelet serotonin and YAP contributed to poor prognosis of hepatocellular carcinoma.

Life sciences·2021
Same author

[Identification and differential expression of miRNA related to seed dormancy of Paris polyphylla var. chinensis].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2021
Same author

Characterization of the complete mitochondrial genome of <i>Diodon liturosus</i> with phylogenetic consideration.

Mitochondrial DNA. Part B, Resources·2021
Same author

The complete mitochondrial genome of <i>Pomacea diffusa</i> (Gastropoda: Ampullariidae).

Mitochondrial DNA. Part B, Resources·2021

Related Experiment Video

Updated: Jan 15, 2026

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.2K

CAR-based cell therapy for autoimmune diseases.

Xiu Li1, Chao He1, Ke Wang2

  • 1Central Laboratory, Department of Clinical Laboratory, Fourth Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.

Frontiers in Immunology
|October 6, 2025
PubMed
Summary

Chimeric antigen receptor (CAR) cell therapies are emerging as a powerful new treatment for autoimmune diseases (AIDs). These engineered cell therapies offer targeted approaches to restore immune balance, moving beyond traditional immunosuppression.

Keywords:
CAR-T cellautoimmune diseasecell therapychimeric antigen receptorsynthetic biology

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.3K
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.4K

Related Experiment Videos

Last Updated: Jan 15, 2026

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.2K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.3K
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.4K

Area of Science:

  • Immunology
  • Cell Therapy
  • Autoimmune Diseases

Background:

  • Chimeric antigen receptor (CAR)-based cell therapies, originally developed for oncology, are now being explored for autoimmune diseases (AIDs).
  • CAR strategies aim to eliminate autoreactive immune cells or restore immune homeostasis, offering alternatives to conventional immunosuppression.

Purpose of the Study:

  • To review current applications of CAR-T cells in AIDs.
  • To discuss emerging CAR-based strategies like CAR-Tregs, CAAR-T cells, CAR-NK cells, and CAR-macrophages.
  • To highlight advances in CAR design and synthetic biology for improved therapeutic precision and control.

Main Methods:

  • Review of current literature on CAR-based cell therapies for autoimmune diseases.
  • Analysis of advancements in CAR design, including antigen selection, co-stimulatory domains, and safety mechanisms.
  • Discussion of emerging CAR cell types and the role of synthetic biology.

Main Results:

  • CAR-T cells show promise for treating autoimmune diseases by targeting autoreactive components.
  • Emerging CAR strategies like CAR-Tregs, CAAR-T, CAR-NK, and CAR-macrophages offer diverse therapeutic potentials.
  • Advances in CAR design and synthetic biology enhance precision and control, while challenges in antigen specificity, persistence, and manufacturing remain.

Conclusions:

  • CAR-based cell therapies represent a promising next-generation treatment option for autoimmune diseases.
  • Continued research in CAR design, safety, and manufacturing is crucial for clinical translation.
  • These engineered cell therapies offer a targeted approach to managing autoimmune conditions.